Rebreath

Revefenacin INN

Respiratory

 
 
 
 
 


Indication

Rebreath is indicated for Maintenance for COPD


Dosage and Administration

IndicationPatient CategoryRecommended dose
Chronic Obstructive Pulmonary Disease (COPD)Pediatric patientsNot recommended dose
Chronic Obstructive Pulmonary Disease (COPD)Adults (18 years & Older)Rebreath 3 ml Nebulizer solution: one ampoule once daily with nebulizer to improve symptoms of COPD
OR, AS DIRECTED BY PHYSICIAN.


Composition

Rebreath 3 ml Nebulizer Solution: Each ampoule of Rebreath contains 3 ml isotonic transparent nebulizer solution that contains Revefenacin INN 175 mcg.